注射药品包装市场规模、份额及成长分析(依产品类型、材料类型、药品类型、最终用户及地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1920007

注射药品包装市场规模、份额及成长分析(依产品类型、材料类型、药品类型、最终用户及地区划分)-2026-2033年产业预测

Parenteral Products Packaging Market Size, Share, and Growth Analysis, By Product Type (Vials, Ampoules), By Material Type (Glass, Plastic), By Drug Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 177 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球注射剂包装市场规模预计在 2024 年达到 298 亿美元,从 2025 年的 319.2 亿美元增长到 2033 年的 552.5 亿美元,在预测期(2026-2033 年)内复合年增长率为 7.1%。

全球注射剂包装市场正经历显着成长,这主要得益于几个关键因素。生物製药和生物相似药的快速发展,以及癌症、糖尿病和自体免疫疾病等依赖注射药物治疗的慢性病病例的增加,推动了对无菌和无污染包装需求的不断增长。此外,卫生监管机构日益严格的监管压力也促使製药公司在包装解决方案中保持更高的安全标准。材料和容器形式的技术创新进一步巩固了市场格局,并有助于进行更精确的分析和预测。总而言之,对安全、有效且技术先进的包装解决方案的需求,持续推动注射剂包装产业的成长。

推动全球注射包装市场发展的因素

糖尿病、癌症和关节炎等慢性疾病发病率的上升显着推动了注射药物的需求。这些治疗需要严格的无菌操作和精确的剂量控制,凸显了高品质注射剂包装的重要性。此外,速效治疗方法和自我给药方式的日益普及进一步加剧了对可靠、易用包装解决方案的需求。随着患者寻求更便利且高效的治疗方案,在确保安全有效用药的推动下,注射剂包装产品市场持续扩张。这种不断变化的市场格局凸显了创新包装在满足医疗需求方面的重要性。

全球注射剂药品包装市场限制因素

使用环烯烃聚合物和涂层玻璃等先进包装材料以及智慧技术会显着增加生产成本,这对中小企业构成挑战。引入无线射频识别(RFID)和防篡改等技术会进一步加重财务负担,并使采用过程更加复杂,尤其是在预算限制明显的市场。因此,这些高成本阻碍了企业改进包装解决方案,限制了其在价格敏感市场环境中的市场准入和创新。这种情况阻碍了全球注射剂产品包装市场的成长潜力,尤其对于营业单位寻求在品质和价格之间取得平衡的企业而言。

注射包装市场的全球趋势

全球注射剂包装市场正呈现显着的技术创新趋势,其特点是整合防篡改功能、智慧感测器和RFID技术。这些创新显着提高了产品可追溯性和药品安全性,同时透过更优异的阻隔材料延长了保质期。此外,包装流程的自动化数位化转型正在提高效率和一致性,促使製药公司投资于尖端的技术主导包装解决方案。这一趋势反映了全球注射剂包装领域对更高安全性、合规性和营运效率日益增长的需求,并正在重塑行业标准和实践。

目录

介绍

  • 调查目标
  • 市场定义和范围

调查方法

  • 调查过程
  • 二手资料和一手资料方法
  • 市场规模估算方法

执行摘要

  • 全球市场展望
  • 市场主要亮点
  • 细分市场概览
  • 竞争格局概述

市场动态与展望

  • 总体经济指标
  • 驱动因素和机会
  • 限制与挑战
  • 供给面趋势
  • 需求面趋势
  • 波特的分析和影响

关键市场考察

  • 关键成功因素
  • 影响市场的因素
  • 关键投资机会
  • 生态系测绘
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管环境
  • 技术评估
  • 技术评估
  • 监管环境

全球注射用药品包装市场规模(依产品类型及复合年增长率划分)(2026-2033 年)

  • 管瓶
  • 安瓿
  • 预填充式注射器
  • 点滴袋
  • 墨水匣

全球注射用药品包装市场规模(按材料类型和复合年增长率划分)(2026-2033 年)

  • 玻璃
  • 塑胶
  • 橡胶帽

全球注射包装市场规模(依药物类型划分)及复合年增长率(2026-2033 年)

  • 小分子药物
  • 生物製药和生物相似药

全球注射剂药品包装市场规模(按最终用户划分)及复合年增长率(2026-2033 年)

  • 製药公司
  • 契约製造组织
  • 医院和诊所

全球注射药品包装市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Gerresheimer
  • Schott AG
  • West Pharmaceutical Services
  • Becton, Dickinson and Company
  • Stevanato Group
  • Nipro Corporation
  • Corning Incorporated
  • AptarGroup
  • Amcor
  • Berry Global
  • Ompi(Stevanato Group)
  • SGD Pharma
  • DWK Life Sciences
  • Catalent
  • Vetter Pharma
  • AR Packaging
  • Shandong Pharmaceutical Glass
  • Terumo Corporation
  • Datwyler Holding
  • UFP Technologies

结论与建议

简介目录
Product Code: SQMIG35I2495

Global Parenteral Products Packaging Market size was valued at USD 29.8 billion in 2024 and is poised to grow from USD 31.92 billion in 2025 to USD 55.25 billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).

The global market for parenteral products packaging is witnessing significant growth driven by several key factors. The rising necessity for sterile and contamination-free packaging aligns with the increasing development of biologics and biosimilars, as well as the escalation of chronic diseases such as cancer, diabetes, and autoimmune disorders that rely on injectable drugs. Additionally, heightened regulatory pressures from health authorities are compelling pharmaceutical companies to uphold superior safety standards in their packaging solutions. Technological innovations in materials and container formats further enhance the market landscape, enabling more refined analysis and projections. Overall, the demand for safe, effective, and technologically advanced packaging solutions continues to shape the trajectory of the parenteral products packaging sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Parenteral Products Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Products Packaging Market Segments Analysis

Global Parenteral Products Packaging Market is segmented by Product Type, Material Type, Drug Type, End User and region. Based on Product Type, the market is segmented into Vials, Ampoules, Prefilled Syringes, IV Bags and Cartridges. Based on Material Type, the market is segmented into Glass, Plastic and Rubber Closures. Based on Drug Type, the market is segmented into Small Molecules and Biologics & Biosimilars. Based on End User, the market is segmented into Pharmaceutical Companies, Contract Manufacturing Organizations and Hospitals & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Parenteral Products Packaging Market

The rising incidence of chronic diseases, including diabetes, cancer, and arthritis, has significantly boosted the demand for injectable medications. These treatments require strict sterility and precision in administration, highlighting the critical need for high-quality parenteral packaging. Additionally, the growing inclination towards fast-acting therapies and self-administration methods enhances the need for dependable and user-friendly packaging solutions. As patients increasingly seek accessible and efficient treatment options, the market for parenteral products packaging continues to expand, driven by a commitment to ensuring safe and effective medication delivery. This evolving landscape underscores the importance of innovative packaging in supporting healthcare needs.

Restraints in the Global Parenteral Products Packaging Market

The use of advanced packaging materials like cyclic olefin polymers, coated glass, and smart technologies contributes significantly to production expenses, posing a challenge for small and medium-sized enterprises. The financial strain intensifies with the incorporation of technologies such as RFID and tamper-evident features, which complicate the adoption process, especially in markets where budget constraints are prevalent. Consequently, these elevated costs create obstacles for businesses aiming to enhance their packaging solutions, limiting market participation and innovation in price-sensitive environments. This situation hampers growth potential in the Global Parenteral Products Packaging market as entities strive to balance quality and affordability.

Market Trends of the Global Parenteral Products Packaging Market

The Global Parenteral Products Packaging market is experiencing a notable trend towards technological advancements, marked by the integration of tamper-evident features, smart sensors, and RFID technologies. These innovations significantly enhance product traceability and drug safety while also extending shelf life through superior barrier materials. Furthermore, the move towards automation and digitalization in packaging processes is improving efficiency and consistency, prompting pharmaceutical companies to invest in cutting-edge, technology-driven packaging solutions. This trend reflects an increasing demand for enhanced safety, regulatory compliance, and operational effectiveness within the global parenteral packaging landscape, reshaping industry standards and practices.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Technology Assessment
  • Technology Assessment
  • Regulatory Landscape

Global Parenteral Products Packaging Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Vials
  • Ampoules
  • Prefilled Syringes
  • IV Bags
  • Cartridges

Global Parenteral Products Packaging Market Size by Material Type & CAGR (2026-2033)

  • Market Overview
  • Glass
  • Plastic
  • Rubber Closures

Global Parenteral Products Packaging Market Size by Drug Type & CAGR (2026-2033)

  • Market Overview
  • Small Molecules
  • Biologics & Biosimilars

Global Parenteral Products Packaging Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Hospitals & Clinics

Global Parenteral Products Packaging Market Size & CAGR (2026-2033)

  • North America (Product Type, Material Type, Drug Type, End User)
    • US
    • Canada
  • Europe (Product Type, Material Type, Drug Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Material Type, Drug Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Material Type, Drug Type, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Material Type, Drug Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Gerresheimer
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Schott AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • West Pharmaceutical Services
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stevanato Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AptarGroup
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amcor
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Berry Global
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ompi (Stevanato Group)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGD Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DWK Life Sciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Catalent
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetter Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AR Packaging
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shandong Pharmaceutical Glass
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Datwyler Holding
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UFP Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations